Parameter
| Biomarker | ctDNA | Full name | Circulating tumor DNA | Molecular Type | Nucleic acid（DNA） |
|---|---|---|---|---|---|
| Molecular Formula | / | Molecular Weight | / | Core Functional Dimensions | Diagnosis, monitoring, and prediction of treatment response |
| Disease | Renal Cell Carcinoma(RCC) | Disease Subtypes | / | ||
| Organ | Kidney | Test Sample / Technology Platform | Peripheral blood (targeted sequencing) | ||
| Pathobiological Mechanisms | Genomic fragments released into the bloodstream by tumor cells reflect the genomic characteristics of the tumor. | ||||
| Clinical Availability Status | Study test / Frontier exploration: Dynamic monitoring of tumor burden and treatment resistance | ||||
| Notes and Dynamics | Detection of gene mutations such as VHL and BAP1, with post-treatment decline indicating efficacy | ||||